The objective of this study is to evaluate the clinical outcomes of the IC-8 IOL implanted in patients with complex corneas after crystalline lens removal.
Who can participate
Age range22 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Minimum 22 years of age;
✓. Able to comprehend and have signed a statement of informed consent;
✓. Availability, willingness, ability and sufficient cognitive awareness to comply with examination procedures and study visit(s);
✓. Planned crystalline lens removal by phacoemulsification, with or without femtosecond laser-assisted extraction, and posterior chamber IOL implantation;
✓. Planned cataract removal or planned clear lens exchange in both eyes
✓. Potential for postoperative best-corrected distance visual acuity (BCDVA) of 20/32 or better after crystalline lens removal;
✓. Having complex corneas with irregular astigmatism
✓. Having clear central cornea
Exclusion criteria
✕. Requiring an IC-8 IOL outside the available spherical power range;
✕. Pharmacologically dilated pupil size less than 6 mm in either eye;
✕. Preoperative corneal astigmatism \>1.50 diopters in the eye to be implanted with the IC-8 IOL;
✕. Active or recurrent anterior segment pathology;
✕. Presence of ocular abnormalities or conditions (other than corneal irregularities) as specified by the protocol;